Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 411-419 of 419 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Global Burden of Disease Study 2013 Collaborators,; Vos, T.; Barber, R.; Bell, B.; Bertozzi-Villa, A.; Biryukov, S.; Bolliger, I.; Charlson, F.; Davis, A.; Degenhardt, L.; Dicker, D.; Duan, L.; Erskine, H.; Feigin, V.; Ferrari, A.; Fitzmaurice, C.; Fleming, T.; Graetz, N.; Guinovart, C.; Haagsma, J.; et al.
2015Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trialCADISS trial investigators,; Markus, H.; Hayter, E.; Levi, C.; Feldman, A.; Venables, G.; Norris, J.; Peycke, J.; Willson, M.; Hicks, C.; Hayter, E.; Madigan, J.; Clifton, A.; Menon, R.; Kennedy, F.; Khan, U.; Feldman, A.; Hollocks, M.; Markus, H.; King, A.; et al.
2010Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and developmentBianco-Miotto, T.; Chiam, K.; Buchanan, G.; Jindal, S.; Day, T.; Thomas, M.; Pickering, M.; O'Loughlin, M.; Ryan, N.; Raymond, W.; Horvath, L.; Kench, J.; Stricker, P.; Marshall, V.; Sutherland, R.; Henshall, S.; Gerald, W.; Scher, H.; Risbridger, G.; Clements, J.; et al.
2017MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2Das, R.; Gregory, P.A.; Fernandes, R.C.; Denis, I.; Wang, Q.; Townley, S.L.; Zhao, S.G.; Hanson, A.; Pickering, M.A.; Armstrong, H.K.; Lokman, N.A.; Ebrahimie, E.; Davicioni, E.; Jenkins, R.B.; Karnes, R.J.; Ross, A.E.; Den, R.B.; Klein, E.A.; Chi, K.N.; Ramshaw, H.S.; et al.
202041BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivoBaroni, M.L.; Sanchez Martinez, D.; Gutierrez Aguera, F.; Roca Ho, H.; Castella, M.; Zanetti, S.; Velasco Hernandez, T.; Diaz de la Guardia, R.; CastaƱo, J.; Anguita, E.; Vives, S.; Nomdedeu, J.; Lapillone, H.; Bras, A.E.; van der Velden, V.H.J.; Junca, J.; Marin, P.; Bataller, A.; Esteve, J.; Vick, B.; et al.
2020Predicting outcomes of pelvic exenteration using machine learningDudurych, I.; Kelly, M.E.; Aalbers, A.G.J.; Abdul Aziz, N.; Abecasis, N.; Abraham-Nordling, M.; Akiyoshi, T.; Alberda, W.; Albert, M.; Andric, M.; Angenete, E.; Antoniou, A.; Auer, R.; Austin, K.K.; Aziz, O.; Baker, R.P.; Bali, M.; Baseckas, G.; Bebington, B.; Bedford, M.; et al.
2008Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genesKisand, K.; Link, M.; Wolff, A.; Meager, A.; Tserel, L.; Org, T.; Murumagi, A.; Uibo, R.; Willcox, N.; Podkrajek, K.; Battelino, T.; Lobell, A.; Kampe, O.; Lima, K.; Meloni, A.; Ergun-Longmire, B.; Maclaren, N.; Perheentupa, J.; Krohn, K.; Scott, H.; et al.
2011Progesterone receptor gene variants and risk of endometrial cancerO'Mara, T.; Fahey, P.; Ferguson, K.; Marquart, L.; Lambrechts, D.; Despierre, E.; Vergote, I.; Amant, F.; Hall, P.; Liu, J.; Czene, K.; SASBAC,; Rebbeck, T.; WISE Study Group,; AOCS Management Group,; SEARCH,; Ahmed, S.; Dunning, A.; Gregory, C.; Shah, M.; et al.
2020The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal CancerChok, A.Y.; Kontovounisios, C.; Rasheed, S.; Kelly, M.E.; Agj, A.; Abdul Aziz, N.; Abecasis, N.; Abraham-Nordling, M.; Akiyoshi, T.; Alberda, W.; Albert, M.; Andric, M.; Angenete, E.; Antoniou, A.; Auer, R.; Austin, K.K.; Aziz, O.; Baker, R.P.; Bali, M.; Baseckas, G.; et al.